Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma
Clinical trial NCT07468630 · RECRUITING
Trial details
- NCT number
- NCT07468630
- Sponsor
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-10
- Primary completion
- 2026-12-31
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.